Par Drugs And Chemicals Limited (PAR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Par Drugs And Chemicals Limited (PAR) has a cash flow conversion efficiency ratio of 0.076x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs80.95 Million ≈ $875.41K USD) by net assets (Rs1.06 Billion ≈ $11.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Par Drugs And Chemicals Limited (PAR) market capitalisation for the company's overall valuation and market capitalisation.
Par Drugs And Chemicals Limited - Cash Flow Conversion Efficiency Trend (2016–2026)
This chart illustrates how Par Drugs And Chemicals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Par Drugs And Chemicals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Par Drugs And Chemicals Limited ranked by their cash flow conversion efficiency. Explore PAR cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Knightscope Inc
NASDAQ:KSCP
|
-0.382x |
|
Seker Finansal Kiralama AS
IS:SEKFK
|
0.184x |
|
Kodi-S Co Ltd
KQ:080530
|
-0.029x |
|
Volitionrx Ltd
NYSE MKT:VNRX
|
0.154x |
|
Salee Colour Public Company Limited
BK:COLOR
|
0.066x |
|
YOC AG
F:YOC
|
0.206x |
|
Lleidanetworks Serveis Telematics SA
MC:LLN
|
0.270x |
|
Telefast Indonesia
JK:TFAS
|
0.023x |
Annual Cash Flow Conversion Efficiency for Par Drugs And Chemicals Limited (2016–2026)
The table below shows the annual cash flow conversion efficiency of Par Drugs And Chemicals Limited from 2016 to 2026. View Par Drugs And Chemicals Limited (PAR) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs1.12 Billion ≈ $12.11 Million |
Rs164.32 Million ≈ $1.78 Million |
0.147x | -10.13% |
| 2025-03-31 | Rs989.75 Million ≈ $10.70 Million |
Rs161.60 Million ≈ $1.75 Million |
0.163x | -30.95% |
| 2024-03-31 | Rs856.32 Million ≈ $9.26 Million |
Rs202.49 Million ≈ $2.19 Million |
0.236x | +25.93% |
| 2023-03-31 | Rs712.38 Million ≈ $7.70 Million |
Rs133.77 Million ≈ $1.45 Million |
0.188x | +47.65% |
| 2022-03-31 | Rs598.77 Million ≈ $6.48 Million |
Rs76.15 Million ≈ $823.55K |
0.127x | -45.05% |
| 2021-03-31 | Rs522.15 Million ≈ $5.65 Million |
Rs120.85 Million ≈ $1.31 Million |
0.231x | +22.22% |
| 2020-03-31 | Rs406.15 Million ≈ $4.39 Million |
Rs76.91 Million ≈ $831.77K |
0.189x | -27.23% |
| 2019-03-31 | Rs291.17 Million ≈ $3.15 Million |
Rs75.77 Million ≈ $819.45K |
0.260x | +24.73% |
| 2018-03-31 | Rs206.99 Million ≈ $2.24 Million |
Rs43.18 Million ≈ $467.01K |
0.209x | -56.32% |
| 2017-03-31 | Rs192.03 Million ≈ $2.08 Million |
Rs91.72 Million ≈ $991.96K |
0.478x | +27.00% |
| 2016-03-31 | Rs173.56 Million ≈ $1.88 Million |
Rs65.27 Million ≈ $705.91K |
0.376x | -- |
About Par Drugs And Chemicals Limited
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, m… Read more